• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Oncology

Specific BRCA1/BRCA2 mutations linked to breast and ovarian cancer risk

byJohn PrendergassandPriyanka Vedak
April 7, 2015
in Oncology, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Multiple breast cancer cluster regions (BCCRs) and ovarian cancer cluster regions (OCCRs) were identified in BRCA1 and BRCA2 genes and were found to confer varying degrees of risk for breast and ovarian cancer.

Evidence Rating Level: 2 (Good)

Study Rundown: BRCA1 and BRCA2 (i.e., breast cancer susceptibility genes) are human genes responsible for producing tumor suppressor proteins, which help repair damaged DNA. While it is currently recognized that mutations to BRCA1 and BRCA2 increase breast and ovarian cancer risk, our understanding of the influence of single specific mutations in the genes is limited.

The authors of this study consequently aimed to identify the influence of the various types and locations of mutations within these genes by performing an observational study on women identified as having pathogenic BRCA1 or BRCA2 mutations. Several breast and ovarian cancer mutation regions were identified in either gene that were associated with relative increases in breast versus ovarian cancer. Strengths of this study include its large sample size from 33 countries, the absence of exclusion of any races or ethnicities, and the variety of BRCA1/2 mutations examined. The study was limited in that there was inadequate power to fully assess the statistical significance of some of the mutations. Nevertheless, with additional studies further validating these results, the findings of this study may eventually be used in the physician’s office to more accurately determine cancer risk and appropriate preventative measures in women with BRCA1/2 mutations.

Click to read the study, published today in JAMA

Relevant Reading: Variation in BRCA1 Cancer Risks by Mutation Position

In-Depth [retrospective cohort]: This study evaluated 19 581 female carriers of BRCA1 mutations and 11 900 carriers of BRCA2 mutations between 1937-2011 from 33 countries. Relative hazard ratios (RHR) for breast and ovarian cancer were identified, with values over 1 indicating an increased risk of breast cancer and with values less than 1 indicating an increased risk of ovarian cancer. Mean age of breast cancer diagnosis was 39.9 years in BRCA1 mutation carriers and 42.8 years in BRCA2 mutation carriers. Mean age of ovarian cancer diagnosis was 50 years in BRCA1 mutation carriers and 54.5 years in BRCA2 mutation carriers. A BRCA1 ovarian cancer cluster region (OCCR) contained within exon 11 suggested a relative decrease in breast cancer and increase in ovarian cancer risk (RHR 0.62; 95%CI 0.56-0.70; FDR-corrected p = 9×10−17). Mutations occurring in the 5′ and 3′ regions of BRCA1 resulted in a relative increase in breast cancer risk and a relative decrease in ovarian cancer risk, defining two breast cancer cluster regions (BCCRs). Similarly, a BRCA2 OCCR was uncovered to increase risk of ovarian cancer vs. breast cancer (RHR 0.51; 95%CI 0.44-0.60; p = 6×10−17). Three BRCA2 BCCRs were found to increase breast cancer risk while decreasing ovarian cancer risk.

RELATED REPORTS

Screening with digital breast tomosynthesis vs mammography associated with significantly lower risk of advanced breast cancer among women with extremely dense breasts at high risk of breast cancer

#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer

Several factors influence health programs conducted in the African American Church

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: brcaBreast Cancer
Previous Post

Specific commercial weight loss programs linked with greater weight loss than education or behavioral counseling

Next Post

Small molecule drug may improve cancer-killing efficacy of oncolytic virus [PreClinical]

RelatedReports

2 Minute Medicine Rewind March 4, 2019
Chronic Disease

Screening with digital breast tomosynthesis vs mammography associated with significantly lower risk of advanced breast cancer among women with extremely dense breasts at high risk of breast cancer

June 16, 2022
#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer
StudyGraphics

#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer

May 18, 2022
Wellness

Several factors influence health programs conducted in the African American Church

May 18, 2022
#VisualAbstract: Aromatase inhibitors significantly reduce recurrence in  premenopausal women with ER+ breast cancer and ovarian suppression
StudyGraphics

#VisualAbstract: Aromatase inhibitors significantly reduce recurrence in premenopausal women with ER+ breast cancer and ovarian suppression

May 3, 2022
Next Post
Small molecule drug may improve cancer-killing efficacy of oncolytic virus [PreClinical]

Small molecule drug may improve cancer-killing efficacy of oncolytic virus [PreClinical]

Increased risk of subsequent melanoma after first melanoma diagnosis

Patients prefer notification of skin biopsy results by phone

Adolescents’ muscle strength associated with lower cardiometabolic risk

Recommended physical activity may provide near-maximal longevity benefit

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • FOLFOX combined with nivolumab and trastuzumab in ERBB2-positive esophagogastric adenocarcinoma is an emerging therapy option
  • Early initiation of poststernotomy cardiac rehabilitation exercise training is effective and safe
  • 2 Minute Medicine Rewind July 4, 2022
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.